1 rich Libsyn https://www.libsyn.com 300 600 ⚡🫀 Shock. Silence. Success — A landmark New England Journal of Medicine trial redefines first-line therapy in persistent AF. &amp;nbsp; In AVANT GUARD, pulsed field ablation (PFA) outperformed antiarrhythmic drugs: 📊 Success: 56% vs 30% 📉 HR: 0.46 (P&amp;lt;0.001) 💓 Lower arrhythmia burden (−6.5%) &amp;nbsp; Safety remained comparable, with primary events at 5.1%. &amp;nbsp; A compelling case for early, energy-based rhythm control—precision over pharmacology. &amp;nbsp; #Cardiology #Electrophysiology #AtrialFibrillation #NEJM #Innovation Dr. RR Baliga's 'Podkast for the Kurious Doc' http://www.MasterMedFacts.com <iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/41025810/height/300/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="300" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe> https://assets.libsyn.com/secure/content/201226765